Related Experiment Video
Updated: Jun 28, 2026

05:44
Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
[Experimental modelling of toxic encephalopathy].
Meditsina Truda I Promyshlennaia Ekologiia
|October 24, 2008
Summary
This study explores experimental models for toxic encephalopathies, focusing on methods to assess central nervous system (CNS) damage from mercury and vinyl chloride exposure. It details approaches for creating and evaluating these critical biologic models.
Area of Science:
- Neuroscience
- Toxicology
- Experimental Biology
Context:
- Toxic encephalopathies pose significant health risks.
- Developing reliable experimental models is crucial for understanding and mitigating neurotoxic effects.
- Existing modeling approaches require systematic evaluation.
Purpose:
- To outline key methodological approaches for experimental biologic modeling of toxic encephalopathies.
- To define criteria and methods for evaluating the pathological condition of the central nervous system (CNS) in these models.
- To present original research on creating models of toxic encephalopathies induced by metallic mercury and vinyl chloride inhalation.
Summary:
- The article reviews established methods for creating and assessing experimental models of toxic encephalopathies.
- It details the evaluation criteria and techniques used to study CNS pathology.
- The authors present their findings on models developed using metallic mercury and vinyl chloride, common industrial toxicants.
Impact:
- Provides a framework for the systematic study of neurotoxic effects.
- Facilitates the development of more accurate preclinical models for toxic encephalopathies.
- Contributes to a better understanding of the mechanisms underlying mercury and vinyl chloride-induced neurotoxicity.
Related Concept Videos
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

